CBP: Section 232 Tariffs Expanded to Copper

CBP: Section 232 Tariffs Expanded to Copper

Effective August 1, Section 232 tariffs on copper imports will come into force, placing copper alongside steel and aluminum as a targeted material under national security trade measures. As with existing steel and aluminum derivative tariffs, importers should expect similar compliance requirements, including the need to identify and report the value and net weight of copper contained within imported goods. Certain derivative HTS classifications will be impacted, making accurate product data and bill-of-materials visibility critical. Importers that lack detailed sourcing and material composition information may face delays, misclassification risk, and unexpected duty exposure as enforcement ramps up.

Read More

Related Posts

DoD: Evolving Priorities in Defense Contracting

The defense contracting landscape is undergoing a fundamental reset. Federal agencies are signaling a shift away from propping up contractors through guaranteed funding and extended timelines. Instead, firms are being pushed to invest their own capital, compete on merit, and deliver capabilities at wartime speed. Agility, innovation, and rapid execution are becoming decisive factors, while…

NMFS: Upcoming Import Prohibitions and Industry Webinars

The National Marine Fisheries Service (NMFS) announces that, effective January 1, 2026, imports of specific fish and fish products from countries whose fisheries have not received comparability findings under the Marine Mammal Protection Act (MMPA) will be restricted from entering the United States. To help industry prepare for these changes, NMFS will host two informational…

CBP: Settlement Reached in Aluminum Extrusions Duty Evasion Case

Harman International Industries, parent company of Harman Kardon®, JBL®, and Mark Levinson®-has agreed to pay $11,809,628 to settle allegations that it evaded antidumping and countervailing duties (ADCVD) on aluminum-extrusion heatsinks imported from China. According to the allegations, the company failed for more than a decade to disclose or correct the violations and actively concealed the…

USTR: U.S. and U.K. Reach Agreement on Pharmaceuticals and Medical Technology

On December 1, 2025, the United States and United Kingdom announced a new agreement on pharmaceuticals, pharmaceutical ingredients, and medical technology. Under this arrangement, the U.S. would remove Section 232 tariffs on U.K.-sourced medical goods, pause any Section 301 investigations related to U.K. pharmaceutical pricing during President Trump’s term, and collaborate to expand U.K. patient…